SUTRO BIOPHARMA, INC.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $58.1M | $190.3M | $69.3M | $47.3M | $30.4M | $206.2M | $5.0M | $125.3M |
| Accounts Receivable | $4.0M | $8.6M | $36.1M | $7.1M | $12.5M | $5.6M | $6.3M | $2.5M |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $150.9M | $343.3M | $421.5M | $353.2M | $218.5M | $378.2M | $128.6M | $209.9M |
| Property, Plant & Equipment | $10.6M | $18.2M | $21.9M | $24.6M | $22.6M | $12.9M | $9.6M | $10.9M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $173.8M | $387.2M | $470.7M | $406.9M | $341.4M | $394.1M | $156.4M | $223.1M |
| Liabilities | ||||||||
| Accounts Payable | $7.6M | $10.5M | $9.4M | $4.8M | $6.0M | $5.5M | $5.6M | $3.1M |
| Total Current Liabilities | $75.1M | $131.9M | $93.7M | $66.5M | $41.7M | $29.6M | $33.0M | $36.4M |
| Long-Term Debt | — | — | $0 | $3.8M | $15.7M | $24.5M | $8.9M | $10.0M |
| Total Liabilities | $306.3M | $342.6M | $321.1M | $189.9M | $88.8M | $62.1M | $58.6M | $91.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-978.0M | $-786.9M | $-559.4M | $-452.6M | $-333.4M | $-227.9M | $-195.7M | $-150.3M |
| Total Stockholders' Equity | $-132.5M | $44.6M | $149.6M | $217.0M | $252.6M | $332.0M | $97.8M | $131.5M |